HomeHealthcare & Life SciencesBiotechnology Preimplantation Genetic Testing Market

United Arab Emirates Preimplantation Genetic Testing Market Size & Outlook, 2025-2033


United Arab Emirates Preimplantation Genetic Testing Market Insights

  • As highlighted in Reed Intelligence analysis, the United Arab Emirates Preimplantation Genetic Testing Market, worth USD 39.37 Million in 2024, is forecasted to achieve USD 73.61 Million by 2033.
  • The United Arab Emirates market is anticipated to grow at a CAGR of 7.17% during the period 2026–2033.
  • By 2024, Preimplantation Genetic Screening (PGS) represented the largest share of the By Procedure market size.
  • Preimplantation Genetic Screening (PGS) is expected to remain the key growth driver within By Procedure, registering the fastest CAGR during the forecast period.

Other Key Findings


  • In 2024, United Arab Emirates represented 4.64% of the overall global Preimplantation Genetic Testing Market size.
  • United States is projected to lead the global Preimplantation Genetic Testing Market size by 2033.
  • Across Middle East and Africa, United Arab Emirates is anticipated to hold the dominant position in market size by 2033.
  • South Africa is forecasted to expand at the fastest pace in Middle East and Africa, attaining USD 11.51 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 39.37 Million
Market Size In 2033 USD 73.61 Million
Largest segment Preimplantation Genetic Screening (PGS)
Units Revenue in USD Million
CAGR 7.17% (2025-2033)
Segmnetation Covered
By Procedure
  1. Preimplantation Genetic Screening (PGS)
  2. Preimplantation Genetic Diagnosis (PGD)
By Product
  1. Reagents and Consumables
  2. Instruments
  3. Software
By Technology
  1. Next-Generation Sequencing (NGS)
  2. Polymerase Chain Reaction (PCR)
  3. Fluorescent In Situ Hybridisation (FISH)
  4. Others
By Application
  1. Chromosomal Abnormalities
  2. Aneuploidy Screening
  3. X-linked Diseases
  4. Embryo Testing
  5. Human Leukocyte Antigen (HLA) Typing
  6. Others
By End-User
  1. Hospitals
  2. Fertility Centres
  3. Diagnostic Centres
  4. Research Centres and Academic Labs
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports